Company Filing History:
1 out of 12 
1 out of 1 Years Active: 2006
Title: The Innovations of Jianmin Shen
Introduction
Jianmin Shen is a notable inventor based in Shenyang, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have therapeutic applications. His work is characterized by a focus on compounds that act as β-receptor agonists, which are essential in treating conditions such as asthma and bronchitis.
Latest Patents
Jianmin Shen holds a patent for a novel invention that provides compounds of formula (I) and pharmaceutically acceptable salts thereof. The invention specifies that Ris can be hydrogen, chlorine, or bromine, while Ris includes electron-attractive groups selected from a variety of options such as CF, CN, fluorine, CHSO, CFSO, and NO. Additionally, Ris can be linear or branched alkyl with 1 to 10 carbon atoms, linear or branched alkoxyalkyl with 2 to 10 carbon atoms, aliphatic alcohol with 1 to 10 carbon atoms, or cycloalkyl with 3 to 6 carbon atoms. The invention also encompasses methods for preparing these compounds and compositions that include them. The compounds developed by Shen have shown efficacy as β-receptor agonists, making them valuable for the treatment of asthma and bronchitis.
Career Highlights
Throughout his career, Jianmin Shen has been associated with prominent institutions such as Shenyang Pharmaceutical University and Jinzhou Jiutai Pharmaceutical Co., Ltd. His work in these organizations has allowed him to advance his research and contribute to the pharmaceutical industry significantly.
Collaborations
Jianmin Shen has collaborated with notable colleagues, including Maosheng Cheng and Li Pan. These collaborations have likely enriched his research and expanded the impact of his inventions.
Conclusion
Jianmin Shen's contributions to pharmaceutical innovations, particularly in the development of β-receptor agonists, highlight his role as a significant inventor in the field. His work continues to influence the treatment of respiratory conditions, showcasing the importance of innovation in healthcare.